Temodal · DIN 02312794 · 140 mg · capsule
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Savings card: RxHelp ONE lists Temodal (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Temodal · DIN 02312794
Manufacturer: Merck Canada Inc.; listing date 2011-09-15
Health Canada: Marketed since 2012-03-23 · brand TEMODAL · ATC L01AX03 TEMOZOLOMIDE · form Capsule · route Oral · ingredients TEMOZOLOMIDE 140 MG · company Merck canada inc · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02312794)
Source record
DIN 02312794: Temodal
Raw flags: sec3=Y
Item: 100000196; group id 186; item number 0339; lccId None; manufacturer id MEK
Source form: Cap; strength: 140mg
Recorded listing: General benefit
Source prices (unrounded): $224.9623; ministry $54.6025
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02312794
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79831
Interchangeable products
Jamp Temozolomide · DIN 02516829 · $54.6025
Taro-Temozolomide · DIN 02443538 · $54.6025
Teva-Temozolomide · DIN 02395290 · $54.6025
Shortage status: not checked (no credentials)